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The purpose of this paper is 3-fold: a) to review briefly the neuropsychological tests that have been
used to evaluate the effects of neurotoxicants; b) to identify individual factors that may create
heightened sensitivity to neurotoxicants; and c) to discuss test parameters that will increase the
sensitivity of neuropsychological tests for detecting symptoms in low-level exposure situations.
While the body of literature on neurobehavioral toxicology has increased dramatically during the
past 10 years, it remains difficult to discern which tests are most effective in detecting behavioral
effects even among workers with significant exposures. Few investigators have evaluated the
interactions between individual differences, such as gender and psychiatric function, and exposure
to neurotoxicants. Detection of behavioral performance decrements among uniquely susceptible
populations such as those with sensitivities to low-level exposures (e.g., multiple chemical
sensitivities) will require more difficult tests than are frequently used in current neuropsychological
test batteries. Environ Health Perspect 104(Suppl 2):239-245 (1996)
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Introduction
Extensive literature documents the range of
neuropsychological tests available to detect
and evaluate symptoms of exposure to
neurotoxicants. By 1990 approximately 250
different tests had been used to evaluate the
effects of neurotoxicants on behavior (1).
Numerous articles have been written in
which the range of functions assessed and
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the specific tests used to assess those func-
tions are reviewed (1-5). Tests applied to
evaluate symptoms among humans derive
from two different psychological approaches:
traditional neuropsychological testing to
diagnose brain dysfunction and experimen-
tal cognitive psychology. Neuropsychology
has traditionally focused on tests to identify
deficits due to pathology (6), while meth-
ods within cognitive psychology have been
developed to elucidate normal cognitive
processes involved in processing ofinforma-
tion and learning (7). This paperwill briefly
review the range of tests used to assess
human responses to neurotoxicants, discuss
measurement ofindividual susceptibility as a
factor in establishing risk status among
patients with sensitivities to low-level expo-
sures, and consider changes in current meth-
ods that will advance measurement oftoxic
symptoms at low-level exposures.
ReviewofCurrentTests
Traditional neuropsychological tests such
as subtests from the Wechsler Adult
Intelligence Scale-Revised (WAIS-R) (8)
and the Halstead-Reitan (9) proved to be
sufficiently sensitive to document cogni-
tive deficits among workers with chronic
exposure to neurotoxicants such as organic
solvents and lead (10,11). Increasingly,
concerns have been raised regarding the sen-
sitivity of these tests for detecting subtle
cognitive deficits at lower level exposures
(12). Nevertheless, several batteries, incor-
porating many ofthe traditional neuropsy-
chological tests, are widely used for clinical
and research purposes (13).
While batteries vary in the specific tests
used, the cognitive functions assessed are
relatively consistent. Table 1 contains a list
ofthe functions assessed and a sample ofthe
tests used to assess these functions. Tests
have been somewhat arbitrarily categorized
into functional categories; however, as sev-
eral other reviewers have suggested, any one
test typically relies on more than one func-
tion for performance (5,6). For example,
even relatively simple tasks such as simple
reaction time require not only attention and
concentration but also motor speed for
accurate and quick responding. Thus, tests
overlap functional categories.
OverallAbility-Verbal
Tests ofoverall verbal ability such as vocab-
ulary tests [e.g., Vocabulary-WAIS-R (8)],
multiple choice vocabulary (16), or reading
scores (e.g., NART-R) (14) are used to esti-
mate premorbid ability. Some studies of
chronic organic solvent or lead exposures
have suggested that such exposure results in
a general dementia affecting all aspects of
cognitive function including word knowl-
edge and general information (25,26).
However, most studies cite verbal ability
tests as methods that are relatively insensitive
to neurotoxicants (6,13). A consistent prob-
lem in studies ofneurotoxicants is the lackof
baseline intellectual function before expo-
sure. Therefore, tests ofcurrent verbal ability
are used as surrogates forpreexposure ability.
OverallAbility-Spatial Relations
Another broad class of tests of ability are
those assessing spatial relations such as
block design from the WAIS-R (8) and
Raven's Progressive Matrices (15). Block
design has been used extensively to evalu-
ate the effects of lead and solvents with
mixed results (27,28). Raven's Progressive
Matrices (15) was designed to assess overall
intellectual ability by presenting visuospatial
conceptual problems rather than verbal con-
ceptual problems (e.g., Similarities-WAIS-
R) and, although less widely used, it has
been sensitive to the effects of neurotoxi-
cants (e.g., mercury) (29).
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Table 1. Functions and representative tests.
Functions Representative tests
Overall cognitive ability,
verbal
Overall cognitive ability,
spatial
Concentration/attention
Motor skills and strength
Visuomotor coordination
Memory
Verbal
Visual
Sensory tests
Audition
Vision
Tactile
Olfaction
Affect/personality
Vocabulary-WAIS-R (8)
National Adult Reading
Test-Revised (14)
Block design (WAIS-R) (8)
Raven's Progressive
Matrices (15)
Simple reaction time
(NES2) (16)
Stroop Color-Word Task
(17)
Continuous Performance
Test(NES2) (16)
Grooved pegboard (9)
Fingertapping (9)
Dynamometer (9)
Hand-eye coordination
test(NES2)(16)
Digit Symbol (WAIS-R) (8)
Logical memory(WMS-R)
(18)
Paired Associates
(WMS-R)(18)
California Verbal Learning
Test(19)
DigitSpan (WAIS-R)(8)
Visual reproduction
(WMS-R) (18)
Complex Figure Test(20)
Audiometer
Seashore rhythm (9)
Colorvision
Finger agnosia (9)
Vibratron (21)
University of Pennsylvania
Smell Identification Test
(22)
Olfactory threshold tests
Profile of Mood States (23)
MMPI-2 (24)
Concentration/Attention
Tests ofconcentration and attention assess
the ability to orient and sustain attention
to either visual or auditory stimuli. This
ability is the precursor to learning and
memory, two functions emphasized in all
batteries ofneuropsychological tests. Tasks
ofconcentration/attention range from sim-
ple reaction time in response to simple
auditory or visual stimuli to more complex
tasks in which the individual must sustain
attention to the target stimulus when dis-
tractors are present, such as the Stroop
Color-Word Task (17), or signal detection
tasks, such as the Continuous Performance
Test (16). Representative tests of atten-
tion/concentration and vigilance are
included in most studies ofneurotoxicants
and are a part of test batteries applied to
worksite testing [e.g., FIOH Battery (30),
WHO Battery (31), London School of
Hygiene Battery (32)]. Gamberale (2) cites
simple reaction time as the most sensitive
test for detecting behavioral performance
effects due to solvent exposure.
MotorSkills
As might be expected, tests ofcognitive skills
are more plentiful than tests ofmotor skills,
particularly tests ofgross as opposed to fine
motor skills. Tests of motor skills assess
speed and dexterity by asking the subject to
place pegs in holes while being timed [e.g.,
grooved pegboard (9), Santa Ana Pegboard
(33)] or measure strength ofgrip bypressure
against a spring-loaded device (dynamome-
ter) (9). Finger tapping (9) is another simple
test ofcoordination and speed that has been
widely used and found sensitive to the effects
ofneurotoxicants (34).
VisuomotorSkills
Another category oftests are those designed
to assess visuomotor skills. At some level,
tests ofattention also require motor skills
since coordination between the perception of
visual stimuli and initiation ofmotor move-
ment is necessary for response. However,
tests ofvisuomotor skills typically involve
more complex levels ofmotor coordination
in response to visual stimuli. For example,
the hand-eye coordination test from the
Neurobehavioral Evaluation System-NES
battery (16) tests the ability to move a com-
puter cursor with a joystick along a sine
wave pattern on a screen at a constant rate
ofspeed. Anothersomewhat more complex,
verbally mediated test ofeye-hand coordi-
nation, widely used in this literature, is
Digit Symbol (8). This coding task requires
that the subject code symbols with letters
while being timed. It has been sensitive to
the effects ofneurotoxicants (e.g., lead, sol-
vents, mercury) (35-37). This test is also
included in most ofthe test batteries used
in worksite testing [e.g., FIOH Battery
(30); TUFF (38)].
Memory
Numerous tests ofmemory have been used
to assess neurotoxicant effects. These tests
range from those assessing memory for
abstract visual designs (e.g., Wechsler
Memory Scale-Revised) (18) to tests of
memory for verbal materials such as words
or numbers [Paired Associates (18), Digit
Span (8)]. The methodology for these tests
usually involves presentation ofthe stimulus
(e.g., drawing or word list) to be encoded.
The subject is asked to recall the stimulus
immediately after presentation as well as
after a relatively short delay (e.g., 30 min).
A more recent development in memory
testing incorporates the tradition ofcogni-
tive psychology by not only providing a
global indicator ofmemory (e.g., total score
based on the quantity remembered) but
also by scoring various indicators ofmem-
ory processes (e.g., slope oflearning curve,
proactive and retroactive interference) (19).
Assessment oflearning curves and memory
processes may provide more insight regard-
ing subtle effects due to relatively low-level
exposures and may help elucidate this fre-
quent complaint that is often not substan-
tiated byglobal tests ofmemory.
Sensory
Sensory tests are not as plentiful and have
not received as much emphasis in the liter-
ature on neurotoxicants as many of the
tests of cognition and memory. Tests of
audition range from simple tests ofhearing
with an audiometer to more complex tests
assessing the ability to discern speech or
rhythmic patterns (e.g., seashore rhythm,
speech perception) (9). Tests oftactile per-
ception and vibration sense include simple
tactile perception (finger agnosia) (9) and
sense ofvibration using a device (21) to
measure perception of fine vibrations in
the finger or toe. These tests have evaluated
loss ofperipheral sensory perception due to
mercury or solvents. Ofmore recent inter-
est is the finding ofcolor vision loss among
solvent-exposed workers (39,40). Finally,
altered sense ofsmell due to neurotoxicants
has received more attention recently
(28,41). Tests ofolfactory discrimination
[University ofPennsylvania Smell Identifi-
cation Test (UPSIT)] (22) and ofolfactory
threshold detection have been used to
evaluate the sense ofsmell.
AflfctandPersonality
Numerous questionnaires and standardized
tests have been used to assess mood and per-
sonality factors that may be affected by
exposure to neurotoxicants. In fact, mood is
reported to be one of the first aspects of
functioning where changes due to neuro-
toxicants can be observed. Irritability,
depression, and lability are mood changes
that are reported to occur in the first stages
ofsolvent neurotoxicity (26). Representa-
tive scales that have been used include the
Profile of Mood States (23), Minnesota
Multiphasic Personality Inventory-2 (24),
and BeckDepression Inventory (42). Unfor-
tunately, these measures rely on self-report
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ofsymptoms rather than any objective indi-
cator ofmood. Therefore, they are subject to
reporting biases that may be influenced by
the circumstances in which the individual is
beingevaluated (e.g., litigation).
Discussion
While numerous cross-sectional studies have
been conducted using various combinations
ofneurobehavioral measures to sample each
of the domains listed above, results from
these studies have been mixed. Some inves-
tigators have attempted to identify patterns
of test performance specific to classes of
neurotoxicants (43,44); however, it has
been difficult to determine a consistent pat-
tern of performance. Numerous reviews
have appeared in which the tests and the
exposures evaluated are listed (5,45). Some
general impressions can be formed from
these reviews suggesting that behavioral
effects are observed for a number of neuro-
toxicants. It is difficult, however, to deter-
mine from these more qualitative reviews
which tests are most sensitive in detecting
effects. Further, little information is avail-
able to document the predictive validity of
these tests forperformance in theworkplace.
Therefore, even if we can say that a test
detects differences in performance between
exposed and nonexposed groups, the mean-
ing of the performance difference has not
been adequately addressed. Information
about this issue could provide the most
compelling evidence for controlling or
reducing exposures.
At this point, there may be sufficient lit-
erature on some organic solvents and heavy
metals such as lead to conduct metaanalyses
ofthe results across studies. These statistical
methods have been used in other literatures
to help consolidate disparate findings into a
more cohesive picture. These methods
could help clarify which tests are most sen-
sitive for detecting effects due to specific
neurotoxicants (46).
For the field of neurobehavioral toxi-
cology to make meaningful advances in our
understanding of the behavioral effects of
neurotoxicants, more refined studies will be
needed. Such studies will also require that
neurobehavioral methods be improved. For
example, rather than continue cross-sec-
tional studies, prospective studies need to
be developed in which workers are followed
over a period oftime to assess changes from
baseline. These will require a better under-
standing ofthe behavior ofneuropsycholog-
ical tests under repeated measures
conditions. Otto et al. (4) found significant
practice effects for several ofthe tests on the
NES battery. To avoid ceiling effects on
these tests after repeated administration, he
suggested that test parameters be altered to
make the tasks more difficult and better
suited to repeated measures design (4).
Similarly, increasing demands are being
made for neuropsychological methods to
assess subtle effects in acute and unusually
low-exposure circumstances. These condi-
tions also require an increased sensitivity in
neuropsychological test methods.
In summary, we need to take a more
systematic approach toward identifying the
most sensitive tests among those cited fre-
quently in the literature. We then need to
test the suitability ofthese tests for the study
designs proposed to address present con-
cerns such as low-level exposures. Further
consideration ofthe parameters to be con-
sidered in these studies will be addressed in
the subsequent sections ofthis paper.
Individual Susceptibility
The test literature reviewed previously pro-
vides an overview ofthe broad range oftests
and functional categories that have been
included in the literature on the effects of
neurotoxicants. While some tests appear to
be more sensitive than others, it is difficult
to develop a clear picture due to the large
variability in the demographic profiles of
the subject groups evaluated, the range of
different substances to which these groups
were exposed, and the lack ofclarity regard-
ing duration and intensity of exposures.
Despite these factors, several attempts have
been made to develop batteries oftests that
can be coordinated across studies [e.g.,
WHO battery (31), NES battery (16)],
thus allowing direct comparisons between
studies. This effort to increase comparability
is to be applauded. However, in an effort to
be broadly applicable, these batteries may
prove insensitive for unique populations or
exposure situations.
For example, an increasing number of
patients have vague complaints, including
poor concentration and memory, in response
to low-level chemical exposures. This symp-
tom complex, labeled multiple chemical
sensitivities (MCS), involves symptoms
reflective ofmultiple organ systems, most
prominently the nervous system. The ques-
tion ofwhether these patients are uniquely
susceptible to chemicals or are a variant of
the psychiatric disorder, somatization, is
frequently debated (47-49).
MCS patients may present unique sus-
ceptibilities to chemicals for several reasons.
First, while no epidemiological studies
have been conducted to date, most of the
investigators observe that approximately
80% ofthese patients are women (49,50).
This is in contrast to the literature on the
neuropsychological effects of neurotoxi-
cants, which is based largely on men. In
one ofthe few studies ofwomen, Parkinson
et al. (51) reported no significant differ-
ences between solvent-exposed blue-collar
women and controls on a relatively brief
battery ofstandard neuropsychological tests.
However, the highest exposure levels were
significantly related to a number ofneuro-
logic and somatic symptoms including
depression and headaches. When symptoms
are reported bywomen, they are more likely
to be attributed to psychosomatic causes
such as stress rather than to physiologically
based conditions (52). This is particularly
true when objective tests do not substantiate
symptom reports. However, it is also possi-
ble that women may have unique suscepti-
bilities that wax and wane due to hormonal
cycles not occurring in men. For example,
women can vary in olfactory acuity accord-
ing to hormonal cycles (53). Alternatively,
women may simply be more aware ofand
likely to report symptoms that occur in
response to an exposure or an illness than
men. That is, women may be better
observers of the early signs ofphysiologic
changes (54). The challenge is to develop
methodologies to measure these changes.
Second, MCS patients have a higher rate
ofpsychiatric disorder (e.g., depression, anx-
iety) concurrent with and before the onset
ofMCS (49,50). Manyuse this information
to suggest that MCS is not a unique suscep-
tibility but simply a psychiatric condition
that is attributed to chemicals. On the
other hand, one may question whether
individuals with psychiatric conditions are
more susceptible to the effects ofneurotox-
icants. For example, Morrow et al. (55)
reported that individuals with higher levels
of psychological distress on the MMPI-2
were associated with poorer neuro-
psychological function at follow-up. From
this study it is impossible to know whether
the symptoms on the MMPI-2 were a
reflection of continuing neurologic symp-
toms due to exposure or a premorbid per-
sonality style. Psychiatric and personality
function, as a risk factor for the effects of
neurotoxicants, has infrequently been eval-
uated and needs further exploration.
Only two studies to date have used
standardized neuropsychological tests to
evaluate the cognitive complaints of MCS
patients (50,56). Overall, these cross-
sectional studies did not find differences
between the MCS and control groups (i.e.,
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musculoskeletal patients, normal controls)
on tests ofconcentration, memory, and
visuomotor skills. However, these tests were
not administered under controlled exposure
conditions. A primary question is how to
test the responses ofMCS patients objec-
tively. The typical evaluation paradigm in
which the patient's neuropsychological per-
formance and physical status is assessed at
an arbitrary point in time is not likely to
capture the symptomatic response that
these patients observe in themselves under
exposure conditions.
Studies more directly relevant to inves-
tigation ofresponses among MCS patients
are exposure chamber studies with sick-
building syndrome (SBS) patients (57,58).
These patients are similar to MCS patients
in that they are otherwise healthy individu-
als who report sensitivities in response to
indoor air mixtures that other individuals
apparently tolerate. Two controlled expo-
sure studies evaluated the effects ofa mix-
ture of 22 volatile organic compounds
(VOCs) on sick-building syndrome patients
relative to asymptomatic controls (57,58).
Along with increasing symptom reports of
irritation with increasing VOC exposure
(0, 5, 25 mg/m3), Molhave et al. (57)
reported reduced performance on digit
span among SBS subjects. This finding was
not replicated, however, when this study
was conducted with young, healthy male
subjects (4). Kjaergaard et al. (58) also
found impaired digit span performance in
SBS-sensitive subjects but not among non-
SBS subjects with exposure at 25 mg/m3
VOC mixture, which is roughly equivalent
to 7 ppm toluene. Otto et al. (4) suggested
that differential effects may be due to dif-
ferential sensitivity ofthe subject groups as
well as relative insensitivity ofmany ofthe
current neurobehavioral methods.
To test the unique susceptibilities of
MCS patients, several factors must be taken
into account. First, like SBS patients, MCS
patients report responses at exposure levels
that most individuals tolerate. For example,
in our current protocol we conduct olfactory
threshold testing in response to phenyl ethyl
alcohol (PEA), a pleasant olfactory stimu-
lant. MCS patients reported significantly
more symptoms than normal controls dur-
ing threshold testing. At suprathreshold lev-
els they reported PEA to be significantly
more unsafe and unpleasant than did nor-
mal controls. From our estimations, the
concentrations at the average olfactory
threshold are comparable to 7 ppm, a level
well below that expected to produce
neurobehavioral performance decrements.
Second, an overriding concern is that
symptomatic responses ofMCS patients are
conditioned responses to olfactory cues
(59). Even among healthy individuals, odor
has been shown to impact performance
(60-62). Neither the studies on SBS sub-
jects nor controlled exposure studies have
adequately accounted for the impact of
odor on performance.
Ideally, controlled exposures with
MCS patients will need to occur below
olfactory thresholds to control for psycho-
logical expectations due to odor. Detecting
effects at such low levels ofexposures (as
low as 1 ppm) will require highly sensitive
behavioral performance measures. Measures
such as reaction time and vigilance tasks
have been the most sensitive indicators in
previous cross-sectional and chamber stud-
ies (2). Therefore, use ofmeasures ofatten-
tion and vigilance similar to those cited in
the signal-detection literature may offer
the best alternative to detect effects among
susceptible individuals and low-level expo-
sure conditions.
TestParameters
Unlike many previous exposure-chamber
studies ofneurotoxicants, exposing sympto-
matic groups such as MCS patients requires
some shifts in the methodologies previously
employed. First, the questions to be
answered depart from the traditional con-
cern for developing workplace standards.
These studies sought to establish the upper
limit ofexposure before objective behavioral
effects were detected. While not necessarily
applicable even to all healthy individuals
working with neurotoxicants, exposure to
these levels among hypersensitive groups
cannot be undertaken for obvious health
and ethical concerns.
As has been suggested by other investi-
gators, one method for detecting effects at
lower exposure levels is to vary parameters
within the performance test to increase its
sensitivity to effects (4,63). Documenta-
tion ofthe effects ofvaried test parameters
has been the subject of much attention
within the experimental literature (e.g., sig-
nal-detection paradigms) and virtually no
systematic attention within the neuropsy-
chological literature or in the literature
investigating the behavioral effects ofneu-
rotoxicants. For example, in the signal-
detection literature, Jansen et al. (64) found
that when signal probability was low, alco-
hol affected stimulus sensitivity and reaction
time ofhits, but the same dose ofalcohol
did not affect these parameters when signal
probability was high. These findings were
not replicated for Diazepam (65). The
findings with alcohol were interpreted to
suggest that reduced response accuracy to
low probability signals would compromise
driving performance since low and variable
signals are likely. Ifonly one stimulus inten-
sity was used, this differential effect ofalco-
hol would nothave been detected.
Detection of effects under exposure
conditions will also require that behavioral
tests be repeated within a relatively short
period of time. Therefore, more informa-
tion is needed to document the effects of
repeated test administration within a brief
time period such as before, during, and
after exposure. This will require that tests
be ofsufficient difficulty to allow variabil-
ity in performance both within and
between subjects.
Behavioral tests that focus on process
rather than a single summary outcome will
be important in the development ofresearch
on low-level exposures. Even in cross-sec-
tional studies ofexposed working popula-
tions, the detection ofbehavioral effects to
objectify symptomatic complaints ofpoor
memory and concentration has been prob-
lematic. This difficulty may be due to the
fact that many ofthe neuropsychological
tests applied to this field offer a summary
score ofperformance (WAIS-R subtests)
rather than assessment oflearning curves or
variables delineating the various functions
that contribute to performance. Thus, sev-
eral investigators have emphasized the
application ofinformation-processing para-
digms and tasks to the assessment ofneuro-
toxicants (43,66).
In our experience with MCS patients,
the tasks most sensitive to behavioral
performance decrements were those in
which subfunctions of the task were
assessed. For example, obtaining scores on
signal-detection parameters for the
Continuous Visual Memory Test (CVMT)
(67) revealed that MCS patients recognized
signals at the same rate as normals (hits) but
over responded to nonsignals (false alarms).
A summary score for this task would sug-
gest impaired visual memory; however,
analysis ofthe subfunctions suggests that
response style may be a more important
variable in their performance. Observation
ofthe distribution ofscores for this group of
patients also suggests that only a subgroup
of the total group (approximately 39%)
exhibited significant impairment (Figure 1).
This finding is consistent with the observa-
tion ofhyperactive children ofWeiss et al.
(68). Inspection ofindividual performance
was more important than looking at overall
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Total raw score
Figure 1. Continuous Visual Memory Test. Data from
Fiedler et al. (50).
group means, which can mask a subgroup
ofhyperresponsive individuals. This is par-
ticularly important when case definitions
for affected individuals such as MCS are
not clear.
In addition to test parameters, a com-
plete characterization ofhost factors such as
psychiatric diagnoses and personality traits is
important. For example, among the follow-
ing variables in the MMPI-2-age, reading
score, and depression-health concerns was
the variable accounting for the highest per-
centage ofvariance in performance on the
CVMT (Figure 2). Health concerns mea-
sures a range ofsomatic symptoms, some of
which can be related to neurologic condi-
tions and some to somatization (69).
90
X 80-
,,70 * * t
C 60*
50-
50 60 70 80 90 100
Health concerns, Tscore
Figure 2. CVMT and MMPI-2 health concerns, MCS
subjects. Data from Fiedler et al. (50).
Previous exposure-chamber studies have
not focused on individual difference vari-
ables, such as mood or the tendency to
somatize, in assessing behavioral response to
neurotoxicants. Documentation of these
variables may be critical in understanding
individual differences in performance
among MCS patients, particularly since
approximately 25% ofMCS patients qualify
for a diagnosis ofdepression (50,56). Little
is known about how depression may inter-
actwith the effects ofneurotoxicants in pro-
ducing behavioral performance decrements.
Finally, as mentioned above, various
odorants may affect behavioral performance
(62). In olfactory research, extensive litera-
ture documents the psychophysical proper-
ties and mechanisms ofodor perception.
However, this literature does not address the
concentration at which symptoms and
objective health effects occur. Studies use
objective behavioral tests (e.g., digit span)
to document the effects ofan odorant but
relate these effects to properties ofthe odor
(e.g., pleasant vs unpleasant, irritating vs
nonirritating) rather than to concentrations
in toxicological terms (60). While these
odor effects may not impact healthy indi-
viduals, the same cannot be presumed in
studies ofsymptomatic individuals such as
MCS patients. Therefore, control or mea-
surement ofthe impact ofodor is critical.
For example, alternate methods for admin-
istering exposures such as dermal routes
could be considered.
Conclusion
Documenting behavioral responses to
neurotoxicants among highly susceptible
individuals places greater demands on the
sensitivity ofneuropsychological methods.
Developing sensitive methods to elucidate
the responses of sensitive individuals will
also improve our approaches in the entire
field ofneurobehavioral toxicology.
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